首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Evidence for anti-Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type I proteins in a population in Irian Jaya Indonesia.
【2h】

Evidence for anti-Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type I proteins in a population in Irian Jaya Indonesia.

机译:印度尼西亚Irian Jaya人群中与人类T型淋巴病毒I型蛋白发生交叉反应的抗恶性疟原虫抗体的证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study was performed to demonstrate the presence of anti-Plasmodium falciparum antibodies in a population living in Irian Jaya, Indonesia that cross-react with human T-lymphotropic virus type I (HTLV-I) proteins. Serum samples from 63 volunteers living in Oksibil, a secluded highland valley in Irian Jaya, were tested for anti-P. falciparum antibodies by an immunofluorescence assay and for anti-HTLV-I antibodies by an enzyme immunoassay (EIA). All samples were positive for anti-P. falciparum antibodies at titers of > or = 1:256. Twenty-four samples were reactive by EIA for HTLV-I, and of these, 23 were tested by western blotting (immunoblotting). Five of the 23 samples were classified as western blot positive and 18 were classified as western blot indeterminate. In competitive blocking assays with malaria proteins, western blot immunoreactivity to all HTLV-I Gag proteins was either reduced or eliminated. Significant reductions in the HTLV-I EIA optical density values of the Oksibil sera occurred when the sera were competitively blocked with the malaria antigens. The optical density values of HTLV-I-positive control sera showed no significant change. Competitive blocking with HTLV-I antigens produced reductions in the optical density values of both the Oksibil sera and the HTLV-I-positive control sera. These data suggest that in this population, anti-P. falciparum antibodies are cross-reactive with HTLV-I proteins in the western blot and EIA tests.
机译:进行这项研究是为了证明居住在印度尼西亚伊里安再也的人群中存在与人I型T淋巴病毒(HTLV-1)蛋白发生交叉反应的抗恶性疟原虫抗体。测试了来自居住在伊里安再也一个偏僻的高地山谷奥克西比尔的63名志愿者的血清样本的抗P抗体。免疫荧光法检测恶性疟原虫抗体,酶免疫法(EIA)检测抗HTLV-1抗体。所有样品抗-P均为阳性。滴度>或= 1:256的恶性疟原虫抗体。 EIA对HTLV-1有24个样品具有反应性,其中23个样品通过Western印迹(免疫印迹)进行了测试。 23个样品中有5个分类为Western blot阳性,18个分类为Western blot不确定。在具有疟疾蛋白的竞争性阻断试验中,降低或消除了对所有HTLV-1 Gag蛋白的western blot免疫反应性。当血清被疟疾抗原竞争性阻断时,Oksibil血清的HTLV-1 EIA光学密度值显着降低。 HTLV-I阳性对照血清的光密度值无明显变化。与HTLV-1抗原的竞争性阻断导致Oksibil血清和HTLV-1阳性对照血清的光密度值降低。这些数据表明,在这种人群中,抗P。在蛋白质印迹和EIA测试中,恶性疟原虫抗体与HTLV-1蛋白具有交叉反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号